Alpha Tau Medical can begin U.S. clinical trials of its cancer-zapping device, thanks to a new permit from the Massachusetts Radiation Control Program.
Read more on Medical Design & Outsourcing here.
Alpha Tau Medical can begin U.S. clinical trials of its cancer-zapping device, thanks to a new permit from the Massachusetts Radiation Control Program.
Read more on Medical Design & Outsourcing here.
![[Labs/02’s IXDen in The Times of Israel] Startup steps up to defend Israel’s water network against Iranian cyberattackers](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
